← Back
$TRDA All transactions

Entrada Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$89K

Shares

8,910

Price

$10

Filed

Nov 24

Insider

Name

WENTWORTH KORY JAMES

Title

Chief Financial Officer

CIK

0001725663

Roles

Officer

Transaction Details

Transaction Date

2025-11-21

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

110,026

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $10.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001725663-25-000004

Form Type

4

Issuer CIK

0001689375

WENTWORTH KORY JAMES's History

Date Ticker Type Value
2026-04-01 TRDA $32K
2025-11-21 TRDA $89K
2025-09-02 TRDA F $9K

Other Insiders at TRDA (90d)

Insider Bought Sold Last
WENTWORTH KORY JAMES
Chief Financial Officer
$32K 2026-04-01